Log on / register
Feedback | Support | My details
Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J
Breast Cancer Res 2006, 8:R13
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Meta-analysis of clodronate and breast cancer survival.
Ha TC, Li H
Br J Cancer 2007 Jun 18, 96:1796-801
 [PubMed Central] [PubMed] [Related articles]
2.
Bisphosphonates: are they standard of care for the treatment of breast cancer?
Pritchard KI
Br J Cancer 2007 Jun 18, 96:1781-2
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.